Skip to content

9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease

9000 URETHRA STUDY: a Prospective, Observational Study About Urethroplasty for Urethral Stricture Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04071925
Enrollment
1000
Registered
2019-08-28
Start date
2019-09-01
Completion date
2029-12-31
Last updated
2024-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urethral Stricture

Keywords

urethral stricture disease, urethral stricture, urethra, urethroplasty

Brief summary

It has been demonstrated that urethroplasty should be considered the gold standard treatment for urethral stricture disease as it yields higher long-term success rates than endoscopic treatment options such as direct vision internal urethrotomy (DVIU) or dilation. Many data about these procedures exist, although most of the publications about urethroplasty are retrospective and involve a tremendous risk of bias. To address these issues, this study is designed to prospectively gain evidence about this matter in all patient subgroups facing a potential treatment with urethroplasty: native men, native women, transmen, transwomen and children.

Interventions

PROCEDUREUrethroplasty

Open reconstructive surgery to restore urethral patency in case of urethral stricture disease.

Sponsors

University Hospital, Ghent
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations. * Patient age ≥ 6 years. * If a patient reaches the age of 18 years, he or she will have to provide a new voluntarily signed written informed consent. All patients reaching the age of 18 years will be contacted by the Principal Investigator or Subinvestigator to provide a new voluntarily signed written informed consent.

Exclusion criteria

\- Absence of signed written informed consent and thus a patient unwilling to participate.

Design outcomes

Primary

MeasureTime frameDescription
Failure-free survivalFrom date of surgery until the date of stricture recurrence or date of death from any cause, whichever came first, assessed up to 120 months postoperativelyInterval between operation and latest follow-up moment at which the patiënt remains failure-free

Secondary

MeasureTime frameDescription
Change in ejaculatory functionFrom the date of preoperative questionnaire completion until 24 months postoperatively.Assessment preoperatively and postoperatively using the MSHQ-EjD (Male Sexual Health Questionnaire - Ejaculatory Dysfunction) short form questionnaire (a 3-item questionnaire, total score on 15, higher score indicating better ejaculatory function)
Change in urinary functionFrom the date of preoperative questionnaire completion until 24 months postoperatively.Assessment preoperatively and postoperatively using the ICIQ-MLUTS (International Consultation on Incontinence Questionnaire - Male Lower Urinary Tract Symptoms) module questionnaire (a 6-item questionnaire, total score on 24, higher score indicating more urinary bother)
Change in erectile functionFrom the date of preoperative questionnaire completion until 24 months postoperatively.Assessment preoperatively and postoperatively using the IIEF-5 (International Index of Erectile Function) questionnaire (a 5-item questionnaire, total score on 25, higher score indicating better erectile function).
Change in quality of lifeFrom the date of preoperative questionnaire completion until 24 months postoperatively.Assessment preoperatively and postoperatively using the EQ-5D-3L questionnaire (a 5-item questionnaire generating a digit score, each of the 5 items can be scored with 1, 2 or 3 (e.g. 11213), higher digit score indicating lower quality of life).
Change in general quality of lifeFrom the date of preoperative questionnaire completion until 24 months postoperatively.Assessment preoperatively and postoperatively using the EQ-VAS (Visual Analogue Scale) (a numeric scale ranging from 0 to 100, higher score indicating better quality of life).
Change in urinary continenceFrom the date of preoperative questionnaire completion until 24 months postoperatively.Assessment preoperatively and postoperatively using the ICIQ-UI (International Consultation on Incontinence Questionnaire - Urinary Incontinence) short form questionnaire (a 3-item questionnaire, total score on 21, higher score indicating more incontinence).

Countries

Belgium

Contacts

Primary ContactNicolaas Lumen
nicolaas.lumen@uzgent.be+32 9 332 22 76
Backup ContactWesley Verla
wesley.verla@uzgent.be+32 9 332 22 76

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026